Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07239440
PHASE2

Clinical Trial to Evaluate the Efficacy and Safety of DA-2811 When Added to Ongoing BT-1 and BT-2 Combination Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control

Sponsor: Dong-A ST Co., Ltd.

View on ClinicalTrials.gov

Summary

This study is a multicenter, double-blind, active-controlled, randomized, parallel clinical trial to evaluate the efficacy and safety of DA-2811 when added to ongoing BT-1 and BT-2 combination therapy in patients with type 2 diabetes who have inadequate glycemic control

Official title: A Multicenter, Double-blind, Active-controlled, Randomized, Parallel Clinical Trial to Evaluate the Efficacy and Safety of DA-2811 When Added to Ongoing BT-1 and BT-2 Combination Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control

Key Details

Gender

All

Age Range

19 Years - Any

Study Type

INTERVENTIONAL

Enrollment

288

Start Date

2025-11

Completion Date

2027-06

Last Updated

2025-11-20

Healthy Volunteers

No

Interventions

DRUG

DA-2811

DA-2811 + DA-2811-R2, orally, once daily

DRUG

DA-2811-C

DA-2811-C + DA-2811-R1, orally, once daily

Locations (1)

Samsung Medical Center

Seoul, South Korea